Updated Jul 16, 2026
Yanai Shlomo has filed 2 SEC Form 4 filings across 2 companies in the last 90 days.

Shlomo Yanai is a corporate executive known for his role as a director at Philip Morris International Inc. He has a background in business management and has held various leadership positions in different industries. Yanai is recognized for his contributions to corporate governance and strategic decision-making within the companies he has served.
| Role | Director |
|---|---|
| Notability | 70/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-08 | AMRX | Amneal Pharmaceuticals, Inc. | M — Option exercise | 34.8K | — | |
| 2026-05-08 | PM | Philip Morris International Inc. | A — Grant or award | 1.1K | $169.93 | $190K |
Shlomo Yanai is a corporate executive known for his role as a director at Philip Morris International Inc. He has a background in business management and has held various leadership positions in different industries. Yanai is recognized for his contributions to corporate governance and strategic decision-making within the companies he has served.…
2 primary Form 4 filings in the last 90 days, covering 2 companies.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Yanai Shlomo profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.